COLOMATE challenge to overcome resistance in metastatic colorectal cancer

被引：0
|
作者：
Yoshino, Takayuki [1 ]
机构：
[1] Natl Canc Ctr Hosp East, Dept Gastroenterol & Gastrointestinal Oncol, Kashiwa, Chiba, Japan
来源：
ONCOLOGY-NEW YORK | 2021年 / 35卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：656 / 657
页数：2
相关论文
共 50 条
  • [21] The Current Molecular Treatment Landscape of Advanced Colorectal Cancer and Need for the COLOMATE Platform
    Ciombor, Kristen K.
    Jones, Jeremy C.
    Strickler, John
    Bekaii-Saab, Tanios S.
    Wu, Christina
    ONCOLOGY-NEW YORK, 2021, 35 (09): : 553 - 559
  • [22] Targeting MET and RON to overcome cetuximab resistance in colorectal cancer.
    Graves-Deal, Ramona
    Bogatcheva, Galina
    Damalanka, Vishnu
    Klampfer, Lidija
    Janetka, James W.
    Coffey, Robert J.
    Singh, Bhuminder
    CANCER RESEARCH, 2021, 81 (13)
  • [23] Drug development to overcome resistance to EGFR inhibitors in lung and colorectal cancer
    Dienstmann, Rodrigo
    De Dosso, Sara
    Felip, Enriqueta
    Tabernero, Josep
    MOLECULAR ONCOLOGY, 2012, 6 (01) : 15 - 26
  • [24] PanitumumabDevelopment of resistance in metastatic colorectal cancer: case report
    Reactions Weekly, 2018, 1715 (1) : 205 - 205
  • [25] CetuximabDrug resistance in metastatic colorectal cancer: case report
    Reactions Weekly, 2017, 1646 (1) : 87 - 87
  • [26] Addressing Resistance to Targeted Therapies in Metastatic Colorectal Cancer
    Jones, Jeremy C.
    Ciombor, Kristen K.
    Wu, Christina
    Bekaii-Saab, Tanios S.
    Strickler, John
    ONCOLOGY-NEW YORK, 2021, 35 (10): : 654 - 660
  • [27] Exploiting clonal evolution and liquid biopsy to overcome resistance to anti-EGFR treatment in metastatic colorectal cancer: the CHRONOS trial
    Siena, Salvatore
    Bardelli, Alberto
    Sartore-Bianchi, Andrea
    Lonardi, Sara
    Leone, Francesco
    Bergamo, Francesca
    Tonini, Giuseppe
    De Braud, Filippo
    Pietrantonio, Filippo
    Rimassa, Lorenza
    Santoro, Armando
    Siravegna, Giulia
    Mussolin, Benedetta
    Rua, Francesco
    Bonazzina, Erica Francesca
    Amatu, Alessio
    Racca, Patrizia
    Ardizzoni, Andrea
    Zagonel, Vittorina
    Marsoni, Silvia
    MOLECULAR CANCER THERAPEUTICS, 2018, 17 (01)
  • [28] A novel second-generation nano-fluoropyrimidine to treat metastatic colorectal cancer and overcome 5-fluorouracil resistance
    Sah, Naresh
    Luna, Pamela
    Mani, Chinnadurai
    Gmeiner, William
    Palle, Komaraiah
    CANCER RESEARCH, 2023, 83 (07)
  • [29] COLOMATE: Colorectal cancer and liquid biopsy screening protocol for molecularly assigned therapy
    Ciombor, Kristen K.
    Ou, Fang-Shu
    Dodge, Andrew
    Zemla, Tyler
    Wu, Christina
    Ng, Kimmie
    Pedersen, Katrina
    Kato, Shumei
    Kasi, Pashtoon M.
    Ahn, Daniel
    Nagy, Rebecca
    Lanman, Richard
    Kopetz, Scott
    Strickler, John H.
    Bekaii-Saab, Tanios
    CANCER RESEARCH, 2019, 79 (13)
  • [30] Chemotherapy re-challenge response rate in metastatic colorectal cancer
    Chambers, Alexandra E.
    Frick, Jacob
    Tanner, Natalee
    Gerkin, Richard
    Kundranda, Madappa
    Dragovich, Tomislav
    JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 9 (04) : 679 - 686
12345